EMEA-000191-PIP01-08-M05
Key facts
| Invented name |
Vfend
|
| Active substance |
voriconazole
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/0151/2013
|
| PIP number |
EMEA-000191-PIP01-08-M05
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
|
| Route(s) of administration |
|
| Contact for public enquiries |
Pfizer Limited
|
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|
| Compliance procedure number |
EMEA-C-000191-PIP01-08-M05
|
| Compliance opinion date |
09/08/2013
|
| Compliance outcome |
positive
|